Ranbaxy, Pharmaceutical Company has opened up its third state of the art drug discovery research centre in Gurgaon which was inaugurated by President A.P.J. Abdul Kalam on 16th August 2005.
Ranbaxy, Pharmaceutical Company has opened up its third state of the art drug discovery research centre in Gurgaon which was inaugurated by President A.P.J. Abdul Kalam on 16th August 2005. The new R&D centre will focus on new drug discovery research and the development functions of medicinal chemistry, analytical development, pharmacology, molecular technologies, infectious diseases, metabolism and pharmacokinetics.
Dr Brian Tempest, CEO & Managing director of Ranbaxy said, “We believe that R&D is one of our key competitive strengths and the addition of this facility further enhances our capabilities in the area of drug discovery and development systems”. This is the third R&D centre which has been set up by Ranbaxy for Drug discovery, all the three modern research facilities is located in the same campus. The First and second R&D centers focus on the development of generics and novel drug delivery systems while the new R&D centre III is dedicated to new drug discovery research. Besides these, Ranbaxy has another R&D building, which houses its regulatory and administrative departments. The focus areas for research for Ranbaxy are infectious diseases, urology, respiratory/inflammatory and metabolic diseases.
